boiler, as you are an expert in all things negative, how come they have re-listed it as phase 2 and phase 3 again?
could it be that it was just a mistake once the GUI of the clinicaltrials website was changed?
or did the FDA all of a suddenly re-deem the trial to be phase 2/3, after temporarily (for 1 month) deeming it to only be a phase 2 trial........
simple human logic, together with kbear's email from the company tells you that it was just a simple mistake, however you probably still fail to acknowledge this
boiler, as you are an expert in all things negative, how come...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |